ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Anti-CCR8 Monoclonal Antibody S-531011 is on this study

  • The record lists it as a treatment, written “S-531011”.
  • A model not recorded judged it tested: part of what the study tests. Nov 1, 2026, 6:35 AM UTC
  • The role rule says the same.
  • So Anti-CCR8 Monoclonal Antibody S-531011's page lists this study under “Testing it”.
4 links0 made here, not in the record7 judgments2 judges (the rules as one: Rule based)0 record changes seen
Model not recordedRule based
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT05101070S-531011 as Monotherapy andin Combination With anImmune Checkpoint Inhibitorin Advanced or MetastaticSolid TumorsShionogiPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSolid TumorsNo longer in the registry's filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSAnti-CCR8 Monoclonal Antibo…Entry “S-531011”, read by our name ru…›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedPembrolizumabIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundBevacizumabIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1Anti-CCR8 Monoclonal Antibody S-531011A model not recordedTestedCurrent
Nov 1PembrolizumabA model not recordedBackgroundCurrent
Nov 1BevacizumabA model not recordedBackgroundCurrent
Nov 14Solid TumorsRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 18Anti-CCR8 Monoclonal Antibody S-531011Rule based · role ruleTestedAgrees
Nov 18PembrolizumabRule based · role ruleBackgroundAgrees
Nov 18BevacizumabRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.